Cargando…
Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
[Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661479/ https://www.ncbi.nlm.nih.gov/pubmed/36270633 http://dx.doi.org/10.1021/acs.jmedchem.2c01414 |
_version_ | 1784830487207870464 |
---|---|
author | Preti, Barbara Suchankova, Anna Deganutti, Giuseppe Leuenberger, Michele Barkan, Kerry Manulak, Iga Huang, Xianglin Carvalho, Sabrina Ladds, Graham Lochner, Martin |
author_facet | Preti, Barbara Suchankova, Anna Deganutti, Giuseppe Leuenberger, Michele Barkan, Kerry Manulak, Iga Huang, Xianglin Carvalho, Sabrina Ladds, Graham Lochner, Martin |
author_sort | Preti, Barbara |
collection | PubMed |
description | [Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were the compounds with a halogen in the meta position on the aromatic ring of the benzyloxy- or phenoxycyclopentyl substituent. In general, the NECA-based compounds displayed greater A(1)R selectivity than the adenosine-based compounds, with N(6)-2-(3-bromobenzyloxy)cyclopentyl-NECA and N(6)-2-(3-methoxyphenoxy)cyclopentyl-NECA showing ∼1500-fold improved A(1)R selectivity compared to NECA. In addition, we quantified the compounds’ affinity and kinetics of binding at both human and rat A(1)R using a NanoBRET binding assay and found that the halogen substituent in the benzyloxy- or phenoxycyclopentyl moiety seems to confer high affinity for the A(1)R. Molecular modeling studies suggested a hydrophobic subpocket as contributing to the A(1)R selectivity displayed. We believe that the identified selective potent A(1)R agonists are valuable tool compounds for adenosine receptor research. |
format | Online Article Text |
id | pubmed-9661479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-96614792022-11-15 Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists Preti, Barbara Suchankova, Anna Deganutti, Giuseppe Leuenberger, Michele Barkan, Kerry Manulak, Iga Huang, Xianglin Carvalho, Sabrina Ladds, Graham Lochner, Martin J Med Chem [Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were the compounds with a halogen in the meta position on the aromatic ring of the benzyloxy- or phenoxycyclopentyl substituent. In general, the NECA-based compounds displayed greater A(1)R selectivity than the adenosine-based compounds, with N(6)-2-(3-bromobenzyloxy)cyclopentyl-NECA and N(6)-2-(3-methoxyphenoxy)cyclopentyl-NECA showing ∼1500-fold improved A(1)R selectivity compared to NECA. In addition, we quantified the compounds’ affinity and kinetics of binding at both human and rat A(1)R using a NanoBRET binding assay and found that the halogen substituent in the benzyloxy- or phenoxycyclopentyl moiety seems to confer high affinity for the A(1)R. Molecular modeling studies suggested a hydrophobic subpocket as contributing to the A(1)R selectivity displayed. We believe that the identified selective potent A(1)R agonists are valuable tool compounds for adenosine receptor research. American Chemical Society 2022-10-21 2022-11-10 /pmc/articles/PMC9661479/ /pubmed/36270633 http://dx.doi.org/10.1021/acs.jmedchem.2c01414 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Preti, Barbara Suchankova, Anna Deganutti, Giuseppe Leuenberger, Michele Barkan, Kerry Manulak, Iga Huang, Xianglin Carvalho, Sabrina Ladds, Graham Lochner, Martin Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists |
title | Discovery and
Structure–Activity Relationship
Studies of Novel Adenosine A(1) Receptor-Selective Agonists |
title_full | Discovery and
Structure–Activity Relationship
Studies of Novel Adenosine A(1) Receptor-Selective Agonists |
title_fullStr | Discovery and
Structure–Activity Relationship
Studies of Novel Adenosine A(1) Receptor-Selective Agonists |
title_full_unstemmed | Discovery and
Structure–Activity Relationship
Studies of Novel Adenosine A(1) Receptor-Selective Agonists |
title_short | Discovery and
Structure–Activity Relationship
Studies of Novel Adenosine A(1) Receptor-Selective Agonists |
title_sort | discovery and
structure–activity relationship
studies of novel adenosine a(1) receptor-selective agonists |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661479/ https://www.ncbi.nlm.nih.gov/pubmed/36270633 http://dx.doi.org/10.1021/acs.jmedchem.2c01414 |
work_keys_str_mv | AT pretibarbara discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT suchankovaanna discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT deganuttigiuseppe discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT leuenbergermichele discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT barkankerry discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT manulakiga discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT huangxianglin discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT carvalhosabrina discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT laddsgraham discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists AT lochnermartin discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists |